» Articles » PMID: 35136009

A Risk Prediction Model for Prolonged Length of Stay in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Retrospective Study of 225 Patients in a Single Center in Kunming, China

Overview
Journal Med Sci Monit
Date 2022 Feb 9
PMID 35136009
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND We aimed to develop an effective prediction model of prolonged length of stay (LOS) in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD). MATERIAL AND METHODS We systematically enrolled 225 patients admitted for AECOPD to our hospital and divided them into a normal LOS group (≤7 days) and prolonged LOS group (>7 days). To analyze differences in laboratory data at different times, 3 logistic regression models were established. To develop the prediction model, all variables with statistical significance were included in the model. The area under the curve (AUC) was used to evaluate discrimination, and the Hosmer-Lemeshow test was used to assess the calibration of the model. RESULTS Factors found to be independently associated with the increased risk of prolonged LOS included the use of corticosteroids during hospitalization, elevated HCO₃⁻, decreased pH, and reductions in platelets (PLTs) and procalcitonin (PCT) between the fourth and first day of hospitalization. The risk prediction model including these factors had an AUC of 0.795, suggesting the good discrimination of our model. The Hosmer-Lemeshow test also showed good calibration of the model, which confirmed its good predictive performance. CONCLUSIONS A clinical prediction model was developed with good predictive performance, which could help clinicians identify patients with a higher risk of prolonged LOS, help shorten hospital stay, reduce the disease burden of patients, and improve the outcomes of AECOPD.

Citing Articles

Prognostic risk prediction model for patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD): a systematic review and meta-analysis.

Xu Z, Li F, Xin Y, Wang Y, Wang Y Respir Res. 2024; 25(1):410.

PMID: 39543648 PMC: 11566839. DOI: 10.1186/s12931-024-03033-4.


A risk nomogram for predicting prolonged intensive care unit stays in patients with chronic obstructive pulmonary disease.

Cheng H, Li J, Wei F, Yang X, Yuan S, Huang X Front Med (Lausanne). 2023; 10:1177786.

PMID: 37484842 PMC: 10359115. DOI: 10.3389/fmed.2023.1177786.

References
1.
Wedzicha J, Seemungal T . COPD exacerbations: defining their cause and prevention. Lancet. 2007; 370(9589):786-96. PMC: 7134993. DOI: 10.1016/S0140-6736(07)61382-8. View

2.
Rabe K, Watz H . Chronic obstructive pulmonary disease. Lancet. 2017; 389(10082):1931-1940. DOI: 10.1016/S0140-6736(17)31222-9. View

3.
Liu H, Zheng D, Lin Y, Liu Z, Liang Z, Su J . Association of sputum microbiome with clinical outcome of initial antibiotic treatment in hospitalized patients with acute exacerbations of COPD. Pharmacol Res. 2020; 160:105095. DOI: 10.1016/j.phrs.2020.105095. View

4.
Ruparel M, Lopez-Campos J, Castro-Acosta A, Hartl S, Pozo-Rodriguez F, Roberts C . Understanding variation in length of hospital stay for COPD exacerbation: European COPD audit. ERJ Open Res. 2016; 2(1). PMC: 5005149. DOI: 10.1183/23120541.00034-2015. View

5.
Garcia-Sanz M, Gonzalez-Barcala F, Canive-Gomez J, Garcia-Couceiro N, Alonso-Acuna S, Carreira J . Prolonged stay predictors in patients admitted with chronic obstructive pulmonary disease acute exacerbation. Lung India. 2018; 35(4):316-320. PMC: 6034377. DOI: 10.4103/lungindia.lungindia_469_17. View